These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 3985181)

  • 1. Blood pressure and norepinephrine spillover during propranolol infusion in humans.
    Best JD; Halter JB
    Am J Physiol; 1985 Apr; 248(4 Pt 2):R400-6. PubMed ID: 3985181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beta-adrenergic blockade decreases norepinephrine release in humans.
    Rosen SG; Supiano MA; Perry TJ; Linares OA; Hogikyan RV; Smith MJ; Halter JB
    Am J Physiol; 1990 Jun; 258(6 Pt 1):E999-1005. PubMed ID: 2163203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Propranolol and atenolol inhibit norepinephrine spillover rate into plasma in conscious spontaneously hypertensive rats.
    Keeton TK; Biediger AM
    Naunyn Schmiedebergs Arch Pharmacol; 1991 Jul; 344(1):47-55. PubMed ID: 1685557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epinephrine and norepinephrine are cleared through beta-adrenergic, but not alpha-adrenergic, mechanisms in man.
    Cryer PE; Rizza RA; Haymond MW; Gerich JE
    Metabolism; 1980 Nov; 29(11 Suppl 1):1114-8. PubMed ID: 6107816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin II and sympathetic activity in patients with congestive heart failure.
    Goldsmith SR; Hasking GJ; Miller E
    J Am Coll Cardiol; 1993 Apr; 21(5):1107-13. PubMed ID: 8384645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Norepinephrine clearance is increased during acute hypoxemia in humans.
    Leuenberger U; Gleeson K; Wroblewski K; Prophet S; Zelis R; Zwillich C; Sinoway L
    Am J Physiol; 1991 Nov; 261(5 Pt 2):H1659-64. PubMed ID: 1951753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Yohimbine increases sympathetic nerve activity and norepinephrine spillover in normal volunteers.
    Grossman E; Rea RF; Hoffman A; Goldstein DS
    Am J Physiol; 1991 Jan; 260(1 Pt 2):R142-7. PubMed ID: 1847020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reflex control of coronary vascular tone by cardiopulmonary receptors in humans.
    Trimarco B; Vigorito C; Cuocolo A; Ricciardelli B; De Luca N; Volpe M; Lembo G; Condorelli M
    J Am Coll Cardiol; 1988 May; 11(5):944-52. PubMed ID: 3356840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of pentobarbital anesthesia on plasma norepinephrine kinetics in dogs.
    Best JD; Taborsky GJ; Flatness DE; Halter JB
    Endocrinology; 1984 Sep; 115(3):853-7. PubMed ID: 6378605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. On the existence of functional beta-adrenoceptors on vascular sympathetic nerve endings in the human forearm.
    Chang PC; Grossman E; Kopin IJ; Goldstein DS
    J Hypertens; 1994 Jun; 12(6):681-90. PubMed ID: 7963493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of propranolol on plasma norepinephrine during sodium nitroprusside-induced hypotension.
    Dean CR; Maling T; Dargie HJ; Reid JL; Dollery CT
    Clin Pharmacol Ther; 1980 Feb; 27(2):156-64. PubMed ID: 7353333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cardiovascular effects of morphine. The peripheral capacitance and resistance vessels in human subjects.
    Zelis R; Mansour EJ; Capone RJ; Mason DT
    J Clin Invest; 1974 Dec; 54(6):1247-58. PubMed ID: 4612057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The acute cardiovascular actions of intravenous thyrotrophin releasing hormone (TRH) in man are mediated by non-catecholaminergic mechanisms.
    Bouloux PM; Corsello S; Besser M; Grossman A
    Br J Clin Pharmacol; 1996 Aug; 42(2):225-32. PubMed ID: 8864322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dose-dependent suppression of norepinephrine appearance rate in plasma by clonidine in man.
    Veith RC; Best JD; Halter JB
    J Clin Endocrinol Metab; 1984 Jul; 59(1):151-5. PubMed ID: 6725520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced sympathetic nervous activity after intravenous propranolol in ischaemic heart disease: plasma noradrenaline splanchnic blood flow and mixed venous oxygen saturation at rest and during exercise.
    Hansen JF; Hesse B; Christensen NJ
    Eur J Clin Invest; 1978 Feb; 8(1):31-6. PubMed ID: 417929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual adrenergic control of renin during nonhypotensive hemorrhage in conscious dogs.
    Blair ML; Hisa H; Sladek CD; Radke KJ; Gengo FM
    Am J Physiol; 1991 Jun; 260(6 Pt 1):E910-9. PubMed ID: 1647672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of plasma catecholamines in humans. Correlation of resting levels with cardiac responses to beta-blocking and sympatholytic drugs.
    Thomas J; Fouad FM; Tarazi RC; Bravo EL
    Hypertension; 1983; 5(6):858-63. PubMed ID: 6140220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of propranolol on noradrenaline kinetics in patients with essential hypertension.
    Esler M; Jackman G; Leonard P; Skews H; Bobik A; Jennings G
    Br J Clin Pharmacol; 1981 Sep; 12(3):375-80. PubMed ID: 7295467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sympathetic influence on cardiovascular responses to sustained head-up tilt in humans.
    Pedersen M; Madsen P; Klokker M; Olesen HL; Secher NH
    Acta Physiol Scand; 1995 Dec; 155(4):435-44. PubMed ID: 8719263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of propranolol on sympathetically mediated leg vasoconstriction in humans.
    Pellinger TK; Halliwill JR
    J Physiol; 2007 Sep; 583(Pt 2):797-809. PubMed ID: 17627989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.